Design and Synthesis of Novel Methotrexate Conjugated MicroRNA Mimic Modified with 5-Fluorouracil and/or Gemcitabine as a Platform Technology for Cancer Treatment
A platform for modifying miRNAs and using the modified miRNAs as novel cancer therapeutics.
RSS.HDBackground> Background: <
Resistance to chemotherapy can be a highly complex issue, with epigenetic alterations playing a key role in tumorigenesis and chemotherapy resistance. The failure to treat several advanced solid tumors can be often attributed...
Published: 3/19/2025
|
Inventor(s): Jingfang Ju, Iwao Ojima, John Yuen, Lei Chen
Keywords(s):
Category(s): Technology Classifications > Therapeutics, Technology Classifications > Drug Design and/or Synthesis, Campus > Stony Brook University
|